- Email: [email protected]
8607463 Microtier - surface - flocculation assay for antigen or antibody screening
New Patents
iv 8607463 MICROTITER - SURFACE FLOCCULATION ASSAY FOR ANTIGEN OR ANTIBODY SCREENING
Nrapendra NATH assigned to AMERICAN NATIONAL RED CROSS An objective microtiter-surface-flocculation assay for antigen or antibody screening. The assay employs slanting solid surface coated with an antibody to a protein in a 'V' shaped microtiter well. The assay is readable by instrument means and is automatable fully or partially. A kit containing various components of the assay is also disclosed.
biologically active copolymers are also useful as growth promoters for animals. Compounds within the biologically-active copolymers of the present invention are effective tumoricidal agents. The biologically-active copolymer of the present invention is a safe and non-toxic formulation that can effectively be administered to animals or humans. The biologically-active copolymer can be mixed in an oil and water emulsion and administered to an animal or human by injection.
8607593
METHODS AND COMPOSITIONS USEFUL IN PREVENTING EQUINE INFLUENZA Beverly DALE, Barbara CORDELL assigned to B1OTECHNOLOGY RESEARCH PARTNERS LIMITED
8607539 BIOLOGICALLY-ACTIVE COPOLYMERS Robert L HUNTER, Robert L H U N T E R assigned to EMORY UNIVERSITY Biologically-active copolymers and compounds that can be safely used to cause the thymus of an animal or human to increase in size, thereby replenishing the T-lymphocyte population. When injected into an animal or human with an antigen, the biologically-active copolymers cause immunosuppression to the antigen. The
Recombinant vaccines for immunizing horses against equine influenza virus (EIV). The DNA sequences encoding the hemagglutinin (HA) and neuraminidase (NA) glycoproteins from the two strains of EIV currently infective in horses are used to construct vaccinia carried vaccines, to design synthetic peptides for primer and booster administration, and to permit recombinant synthesis of HA and/or NA protein based vaccines. These DNA sequences also provide probes useful for preparing similar vaccines from fresh isolates of new strains generated by genetic drift.
For information about PATSEARCH ~
Pergamon InfoLine Inc. 1340 Old Chain Bridge Road McLean, Virginia 22101 USA Telephone (703) 442-0900 Telex: 90-1811
Pergamon InfoLine Limited 12 Vandy Street London EC2A 2DE England Telephone (01) 377-4650 Telex: 8814614
Pergamon Press Canada Ltd 150 Consumers Road, Suite 104 Willowdale, Ontario Canada M2J 1P9 Telephone (416) 497-8337
iv 8607463 MICROTITER - SURFACE FLOCCULATION ASSAY FOR ANTIGEN OR ANTIBODY SCREENING
Nrapendra NATH assigned to AMERICAN NATIONAL RED CROSS An objective microtiter-surface-flocculation assay for antigen or antibody screening. The assay employs slanting solid surface coated with an antibody to a protein in a 'V' shaped microtiter well. The assay is readable by instrument means and is automatable fully or partially. A kit containing various components of the assay is also disclosed.
biologically active copolymers are also useful as growth promoters for animals. Compounds within the biologically-active copolymers of the present invention are effective tumoricidal agents. The biologically-active copolymer of the present invention is a safe and non-toxic formulation that can effectively be administered to animals or humans. The biologically-active copolymer can be mixed in an oil and water emulsion and administered to an animal or human by injection.
8607593
METHODS AND COMPOSITIONS USEFUL IN PREVENTING EQUINE INFLUENZA Beverly DALE, Barbara CORDELL assigned to B1OTECHNOLOGY RESEARCH PARTNERS LIMITED
8607539 BIOLOGICALLY-ACTIVE COPOLYMERS Robert L HUNTER, Robert L H U N T E R assigned to EMORY UNIVERSITY Biologically-active copolymers and compounds that can be safely used to cause the thymus of an animal or human to increase in size, thereby replenishing the T-lymphocyte population. When injected into an animal or human with an antigen, the biologically-active copolymers cause immunosuppression to the antigen. The
Recombinant vaccines for immunizing horses against equine influenza virus (EIV). The DNA sequences encoding the hemagglutinin (HA) and neuraminidase (NA) glycoproteins from the two strains of EIV currently infective in horses are used to construct vaccinia carried vaccines, to design synthetic peptides for primer and booster administration, and to permit recombinant synthesis of HA and/or NA protein based vaccines. These DNA sequences also provide probes useful for preparing similar vaccines from fresh isolates of new strains generated by genetic drift.
For information about PATSEARCH ~
Pergamon InfoLine Inc. 1340 Old Chain Bridge Road McLean, Virginia 22101 USA Telephone (703) 442-0900 Telex: 90-1811
Pergamon InfoLine Limited 12 Vandy Street London EC2A 2DE England Telephone (01) 377-4650 Telex: 8814614
Pergamon Press Canada Ltd 150 Consumers Road, Suite 104 Willowdale, Ontario Canada M2J 1P9 Telephone (416) 497-8337